Thursday - March 26, 2026

Category Archives: Pharmaceuticals & Biotech

Asthma Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | GlaxoSmithKline, AB Science, Areteia Therapeutics, ARS Pharma, AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharma

The Key Asthma Companies in the market include – GlaxoSmithKline, AB Science, Areteia Therapeutics, ARS Pharmaceuticals, Inc., AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharma, Genentech Research, Roche, Suzhou Connect Biopharmaceuticals, Avalo Therapeutics, 4D Pharma plc, Sterna Biologicals, Cipla Ltd., Global United … Continue reading →

Projecting the Global Vitrectomy Devices Market Size to Expand at a 5.29% CAGR Through 2032, DelveInsight Analysis

Vitrectomy Devices Market Insights, Competitive Landscape, and Market Forecast – 2032” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. As per DelveInsight’s assessment, The vitrectomy devices market is primarily driven by the … Continue reading →

Projecting the Global Blood Collection Devices Market Size to Expand at a 6.41% CAGR Through 2032, DelveInsight Analysis

  As per DelveInsight’s assessment, The global blood collection devices market is being driven by the rising incidence of chronic and infectious diseases, growing demand for blood and its components in transfusions and therapeutic uses, and the increasing adoption of … Continue reading →

Spinal Muscular Atrophy Pipeline 2026: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Genentech, Chugai Pharma, Cytokinetics, Ionis Pharma, Genzyme Corp

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Spinal Muscular Atrophy pipeline constitutes 18+ key companies continuously working towards developing 20+ Spinal Muscular Atrophy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading →

Osteoarthritis Clinical Trial Pipeline Advances as 100+ Companies Develop 110+ Novel Therapies Across All Clinical Stages, Finds DelveInsight | Biosplice Therapeutics, Regeneron Pharmaceuticals

Osteoarthritis – Pipeline Insight, 2026 The leading Osteoarthritis companies include Biosplice Therapeutics, Cynata Therapeutics, Bone Therapeutics S.A, Regeneron Pharmaceuticals, Techfields Pharma, Ampio Pharmaceuticals, Asahi Kasei Pharma, Taiwan Bio Therapeutics, OliPass Corporation, Bioventus, Medipost, LG Chem, ICM Biotech, UnicoCell Biomed, Magellan … Continue reading →

Non Muscle Invasive Bladder Cancer Pipeline Expands as 20+ Pharma Companies Progress Novel Therapies Toward Market Entry, Finds DelveInsight | CG Oncology, Janssen, Tyra Biosciences, UroGen Pharma

Non Muscle Invasive Bladder Cancer – Pipeline Insight, 2026 According to DelveInsight’s report, the leading Non Muscle Invasive Bladder Cancer companies include CG Oncology, Janssen Research & Development LLC, Tyra Biosciences Inc., UroGen Pharma Ltd., Prokarium Ltd., Protara Therapeutics, ImmVira … Continue reading →

Non Muscle Invasive Bladder Cancer Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Non Muscle Invasive Bladder Cancer Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in the Non Muscle Invasive Bladder Cancer pipeline landscape. It covers the Non Muscle Invasive Bladder Cancer pipeline drug profiles, … Continue reading →

Respiratory Syncytial Virus Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Respiratory Syncytial Virus Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Respiratory Syncytial Virus (RSV) pipeline landscape. It covers the Respiratory Syncytial Virus pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Hepatic Tumor Clinical Trial Pipeline Shows Potential with Active Contributions from 75+ Key Companies | DelveInsight

DelveInsight’s, “Hepatic Tumor Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Hepatic Tumor pipeline landscape. It covers the Hepatic Tumor pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Recurrent or Metastatic Head and Neck Cancer Clinical Trial Pipeline Accelerates as 40+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Recurrent or Metastatic Head and Neck Cancer Pipeline Insight 2026” report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in Recurrent or Metastatic Head and Neck cancer pipeline landscape. It covers the Recurrent or Metastatic Head and … Continue reading →